Lowering the Barriers to Medication Treatment for People with Opioid Use Disorder: Evidence for a Low-Threshold Approach

Loading...
Thumbnail Image
Penn collection
Issue Briefs
Degree type
Discipline
Subject
overdose
opioid
opioid epidemic
substance use
Health Law and Policy
Health Services Research
Funder
Grant number
Copyright date
Distributor
Author
Aronowitz, Shoshana V
Behrends, Czarina Navos
Lowenstein, Margaret
Schackman, Bruce
Weiner, Janet
Contributor
Abstract

Overdose deaths have reached unprecedented levels in the U.S., despite effective medications to treat opioid use disorders (OUDs). Because the regulatory and administrative barriers to treatment are high, only about 11% of people with OUD receive effective medications, which include buprenorphine, methadone, and naltrexone. In response, clinicians and advocates have looked to a “low-threshold” approach that reduces the stigma surrounding effective medications and facilitates their use. This brief summarizes the barriers to treatment, the evidence on the low-threshold approach, and areas for future research. The evidence suggests that low-threshold approaches can increase access to treatment, with outcomes comparable to high-barrier, standard care. Policymakers, providers, and payers should lower the barriers to medication treatment through regulatory flexibility (including telehealth prescribing), and harm reduction strategies that de-emphasize abstinence and place a priority on initiating or re-initiating treatment whenever and wherever individuals are ready to do so.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2022-01-27
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
LDI briefs are produced by LDI's policy team. For more information please contact Penn LDI at pennldi-info@wharton.upenn.edu
Recommended citation
Collection